Open Orphan (ORPH)

Sector:

Health Care

Index:

FTSE AIM All-Share

11.75p
   
  • Change Today:
    -0.25p
  • 52 Week High: 16.00
  • 52 Week Low: 4.55
  • Currency: UK Pounds
  • Shares Issued: 663.86m
  • Volume: 810,587
  • Market Cap: £78.00m
  • RiskGrade: 414

Open Orphan signs deal with Empiric Logic to complete Health Data platform

By Josh White

Date: Tuesday 15 Oct 2019

LONDON (ShareCast) - (Sharecast News) - Europe-focussed rare and orphan drug consulting services platform provider Open Orphan has signed a new strategic collaboration agreement with Empiric Logic, it announced on Tuesday, to build on the earlier work it had performed, and complete the build out of its 'Health Data' platform as Europe's first rare disease, advocacy-led genomic database.
The AIM-traded firm said Empiric Logic - a managed software service company which provides software to the life sciences, pharmaceuticals, pharma services and biotechnology sectors - would incorporate its propriety, privacy preserving, and artificial intelligence-enabled software into Open Orphan's Health Data platform, to aid the collection and management capabilities of the software.

It said the collaboration was the final stage in the completion of its Genomic Health Data platform, and would speed up its launch.

The platform built on the genomic analysis, database architecture know-how and prior professional experience between the founders of Empiric Logic and Open Orphan's chief commercial officer Maurice Treacy.

"This is an exciting step towards the completion of our genomic Health Data platform, and we are delighted to have Empiric on board to help us quickly and securely become one of the largest databases of rare disease patients in Europe," said Open Orphan chief executive officer Cathal Friel.

Gareth O'Sullivan, CEO at Empiric Logic, added that his company was "delighted" to be supporting the Open Orphan team with the final steps of preparing the Genomic Health Data platform to accept its first data.

"As part of the rollout of the Open Orphan database, it will be making substantial use of our artificial intelligence capabilities, such as for identification of rare-disease genetic mutations, but also for the potential identification of patients for clinical trials going forward," O'Sullivan explained.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Open Orphan Market Data

Currency UK Pounds
Share Price 11.75p
Change Today -0.25p
% Change -2.08 %
52 Week High 16.00
52 Week Low 4.55
Volume 810,587
Shares Issued 663.86m
Market Cap £78.00m
RiskGrade 414

Open Orphan Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.54% below the market average67.54% below the market average67.54% below the market average67.54% below the market average67.54% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average
Price Trend
95.30% above the market average95.30% above the market average95.30% above the market average95.30% above the market average95.30% above the market average
79.49% above the sector average79.49% above the sector average79.49% above the sector average79.49% above the sector average79.49% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Open Orphan Dividends

No dividends found

Trades for 09-Jul-2020

Time Volume / Share Price
12:04 8,205 @ 11.74p
12:00 20,000 @ 11.80p
12:00 44,685 @ 11.75p
11:48 20,000 @ 11.80p
09:45 150,000 @ 11.92p

Open Orphan Key Personnel

CFO Leo Toole

Top of Page